Connect with us


New Hires by Elixinol Wellness Limited (OTCMKTS: ELLXF) will Strengthen Commercial and R&D Capabilities



Since its establishment in 2014, Elixinol Wellness Limited (OTCMKTS: ELLXF) has held tightly on its mission of positive contribution to people’s health & wellbeing. The company’s 25 years’ experience in hemp has transformed it into a global leader in the hemp industry. Some of its international operations are strategically located in America, Australia, Europe, and the UK. Meanwhile, plans are underway to expand its distribution network. 

The company works closely with farmers, and from seed to sale, the quality of products and processes are upheld. And as the demand for hemp-derived CBD products continues to grow worldwide, health professionals and consumers are joining the bandwagon to advocate their health benefits. 

Expansion of the Company’s Leadership Team

Elixinol has continued to be very strategic in its operations as it ensures an accelerated path of profitability. Among those who will drive up the company’s transformation are Rob Hasselman, the new President Americas, and Beata Silber, the new Global Head of R&D and Innovation. The duo will start by repositioning the business into a path of revenue growth. Silber is mainly a massive coup for the company. Through R&D and Innovation, he will be expected to drive Elixinol’s focus into bringing unique, science-led products to its global markets. 

“Elixinol Wellness has long been at the forefront of the hemp / CBD industry and has a strong reputation for quality…I look forward to working closely with the team to develop products that are innovative…and backed by scientific credibility.” Silber explained while promising to ensure the company stays ahead of global health trends while remaining aligned to consumer needs.

The addition of Elixinol CEO of Americas to its Board of Directors

Tom Siciliano is now part of Elixinol’s Board of Directors and will work closely with the U.S. Hemp Authority® (USHA). According to USHA’s President, Dr. Marielle Weintraub, Siciliano’s extensive background in the cannabis industry is the best thing Elixinol can tap from him. His last work in the cannabis space has successfully orchestrated several turnaround results. The company is already making positive airwaves with its commitment to product efficacy and transparency, solidifying its involvement with the Authority.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.